Paying for open access has been on my mind recently. All those “open choice”, “author choice”, “open option”, “open article”, “online open”, “open science” and other similar schemes (why does each publisher have to have a different name for the same thing?!?), they create a need for someone to pay a fee in order to get their article published. Richard has already commented on this , highlighting the RIN’s recent report on the topic.
My preoccupation has been occasioned partly by discussions with our procurement people yesterday about how we purchase journals (in preparation for the RCUK Shared Services Centre). The possible impact of open access on journal subscriptions occasioned a lengthy detour to explain what OA was and what the strategic implications were for procurement. That moved us into high-level RCUK strategy on research outputs, which is the terrain of the RCUK Research Outputs Group, who recently issued their own report .
When I returned to my office I found a flyer from the Portland Press with news of its new open access journal ASN Neuro . I was perplexed briefly as it mentioned an “Institutional Membership rate of $630”. Sounds like a subscription, but it’s not – the journal is Open Access so it can’t be. No, this membership gives you a $210 discount off the publication charge for any papers that your institution’s authors may publish.
Other publishers have similar things – OUP’s Nucleic Acids Research has morphed its online subscription into an institutional membership that confers discounts on publication charges. Some, such as PNAS give a discount on publication fees to any institution with an institutional site licence.
The Portland Press flyer also mentioned their new Opt2Pay (cute name) scheme, also with a tie-in to subscriptions.
And of course BioMedCentral have had an Institutional membership scheme for some time. In its early years this did not look very attractive as we were publishing little with BMC journals, and the membership charge was relatively high. I think they have modified the scheme, with more options, now and I really must look at it again. PLoS also had an institutional membership scheme, but it required quite a strong commitment. I really need to check it out again.
I can see that the link between subscriptions and OA fees is going to give me a few headaches when I try to figure out what journals we can afford for next year.
-
Recent Posts
Recent Comments
- Frank Norman on My lovely sister, 1946-2025
- Mary Crickard on My lovely sister, 1946-2025
- Frank Norman on My lovely sister, 1946-2025
- Patti Biggs on My lovely sister, 1946-2025
- Frank Norman on My lovely sister, 1946-2025
Archives
- April 2025
- March 2025
- December 2024
- November 2024
- September 2024
- May 2024
- March 2024
- February 2024
- April 2023
- April 2022
- January 2022
- September 2021
- June 2021
- February 2019
- December 2018
- November 2018
- September 2018
- August 2018
- July 2018
- June 2018
- July 2017
- June 2017
- May 2017
- April 2017
- December 2016
- October 2016
- September 2016
- August 2016
- June 2016
- March 2016
- April 2015
- December 2014
- November 2014
- October 2014
- September 2014
- March 2014
- February 2014
- January 2014
- December 2013
- November 2013
- October 2013
- August 2013
- July 2013
- April 2013
- March 2013
- February 2013
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- November 2008
- October 2008
- September 2008
- August 2008
Categories
- AI
- Archives
- Art
- Authorship
- Bibliographic management
- Bibliometrics etc
- Biographical
- Blogology
- Books
- Collections
- Communicating science
- Copyright and IP
- Crick
- Document delivery
- E-books
- Education
- Ethics
- Family
- Film
- Film and music
- Friends
- Froth
- Future of Libraries
- History
- Information skills
- Journal publishing
- Language
- Libraries and librarians
- Management
- Mentoring
- Metadata
- Music
- Open Access
- Open Science
- Peer review
- Preprints
- Reading recommendations
- Research Councils
- Research data
- Research management
- Research tools
- Scientific literature
- Searching
- Social networking
- Uncategorized
- Wikipedia
- Women
- Writing
Blogroll
Meta
As a past employee of an unnamed major publisher, I was somewhat chilled by the glee with which a senior employee there related the influence that they (through the PRC) had had on the selection of the analysts commissioned to produce the RIN report you mention. The report is better than previous attempts, but glosses over the fact that most open access journals (including ours) charge no publication fees whatsoever..something that is still often ignored in discussions about OA, and something worth bearing in mind when you’re thinking about your author-side costs for next year!
Tom – I’m not familiar with the PRC. A quick search suggests it may be the Publishing Research Consortium ? Did your publishing friend mean to suggest that the RIN report on paying OA fees was in some way biased? It didn’t come across that way to me.
Your statement that most open access journals (including ours) charge no publication fees whatsoever rather surprises me. I wonder what your definition of “open access journal” is?
Responding to your post, Frank, rather than the discussion on it so far, I think another issue for journals is simply a technical one. Delivery of a range of publishing options isn’t that straightforward, and at the very least adds a cost (for a journal to offer a range of author and/or reader options and to deliver the online technology that makes that work for individual and site-licence subscribers).
It surprised me too when I heard it..
I think the finding first surfaced in this report. This is based on journals in the DOAJ, so follows their definition: “We define open access journals as journals that use a funding model that does not charge readers or their institutions for access. From the BOAI definition [1] of “open access” we take the right of users to “read, download, copy, distribute, print, search, or link to the full texts of these articles” as mandatory for a journal to be included in the directory.”
This doesn’t of course mean that it’s “free”, but it does mean a rethink about what the real costs of changing publication models are, perhaps.
I actually think the RIN report is pretty measured, and carried out in good faith – any study like this has to based on some assumptions, and I don’t know if the ones chosen are necessarily biased.
What bothered me was the implied acknowledgement that had the PRC (sorry, yes – publishing research consortium) not influenced the choice of analysts, the outcome of the report could have been different.
@Maxine – of course everything has a cost, that’s not surprising. I was just trying to highlight that subscription cost and article fees are now becoming more entangled. So as a librarian I have to take a more complex decision. Not just “do we need to subscribe to this title and how much value (use) will it get?” but also “and how many (if any) articles are we like to publish in it and what can we save in OA fees by having a subscription?”
@Tom. I am still a bit sceptical. I recall, back in the 1990s when digital publishing was in its infancy, there were lists produced revealing large numbers of e-only peer-reviewed journals. This was cited as evidence that online journals could be serious beasts. But when I looked at the lists I could find very very few journals in basic biomedical sciences (the field I know best). I suspect that the same may apply to that statistic about large numbers of free-to-publish OA journals.
All those “open choice”, “author choice”, “open option”, “open article”, “online open”, “open science” and other similar schemes (why does each publisher have to have a different name for the same thing?!?)
That’s an interesting point, Frank. I think all these names reflect the different ways each publisher defines ‘their’ version of Open Access (this is touched on here). There does not seem to be a clear ‘industry standard’ yet, which would be a very important point to address (soon).
That may be a fair point – I don’t know if there’s a breakdown by journal available. Perhaps anyway it would be more useful to know what proportion of articles published didn’t require author fees, instead – as that would include waived fees for example, and give a better idea of the actual proportion of research output involved.
But whether or not the actual percentage itself is meaningful, it still gave me cause to rethink the economics and incentives of the whole thing. I’m new to OA myself and was surprised to find a number of big, successful OA journals in our field alone that run without author charges (Emerging Infectious Diseases is a good example).
Tom – EID is an interesting example, plus its Euro coounterpart, Eurosurveillance. Both of these I think are supported by official sources – EID by the US CDC and Eurosurveillance by the ECDC. In other words, supported by taxpayers as they are an important component of disease surveillance.
I don’t think that model extends into other subject domains.
My $0.02
The following comes to mind.
But the next time you hear someone talk about the “cost” of publishing in OA journals, please point ’em here.
That was Bill Hooker from 2nd Dec 2007 referring to this post on his blog, Open Reading Frame.
Yes – although EID’s remit extends beyond surveillance, I agree that model won’t work in all cases – but you could perhaps imagine equivalent bodies deciding to support an open access journal for clinical research, say. But there are other models. BMJ relies on print subscriptions and advertising – and it’s not just a question of size: Molecular Medicine does the same.